Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 déc. 2003 01h30 HE | Source: Novartis Pharma AG

Sandoz acquires antibiotics production facility

Sandoz acquires antibiotics production facility in Spain Acquisition strengthens in-house production and adds freeze-drying technology Vienna, 11 December 2003 - Sandoz, the generics business unit of...
09 déc. 2003 03h40 HE | Source: Novartis Pharma AG

Novartis ehrt Wissenschaftler

Novartis ehrt Wissenschaftler für herausragende Beiträge Höchste interne wissenschaftliche Auszeichnung geht an Chemiker, der an der Entdeckung von Glivec® massgeblich beteiligt...
08 déc. 2003 03h00 HE | Source: Novartis Pharma AG

New Data Show Higher Dosing of Gleevec Achieved Higher Response Rates in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML)

Early Findings Among Clinical Research Presented at American Society of Hematology (ASH) Meeting; At 12 months, 92% of evaluable CML patients taking 800 mg Gleevec achieved a CCR compared to 72%...
08 déc. 2003 03h00 HE | Source: Novartis Pharma AG

Post-tamoxifen Use Of Femara In Postmenopausal Women With Early Breast Cancer Reduced Risk Of Recurrence By Nearly Half (43%) and Significantly Improved Disease-Free Survival, According to Data Presented at Major Medical Meeting

Extended adjuvant data presented at San Antonio Breast Cancer Symposium supported by new data on quality of life with Femara vs. placebo, from same clinical trialEast Hanover, NJ, December 5, 2003 -...
01 déc. 2003 06h00 HE | Source: Novartis Pharma AG

Geneva Pharmaceuticals, Inc., renamed Sandoz, Inc. - New Name Symbolizes Global Strength -

PRINCETON, NEW JERSEY, December 1, 2003. Geneva Pharmaceuticals, Inc., a Novartis company and one of the leading Generic pharmaceutical companies in the U.S., announced it will be conducting its...